Müller CE - Search Results

1

N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.

Hernandez-Olmos V, Abdelrahman A, El-Tayeb A, Freudendahl D, Weinhausen S, Müller CE. Hernandez-Olmos V, et al. Among authors: muller ce. J Med Chem. 2012 Nov 26;55(22):9576-88. doi: 10.1021/jm300845v. Epub 2012 Nov 1. J Med Chem. 2012. PMID: 23075067

2

7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.

Müller CE, Hide I, Daly JW, Rothenhäusler K, Eger K. Müller CE, et al. J Med Chem. 1990 Oct;33(10):2822-8. doi: 10.1021/jm00172a023. J Med Chem. 1990. PMID: 2213835

3

Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.

Grahner B, Winiwarter S, Lanzner W, Müller CE. Grahner B, et al. Among authors: muller ce. J Med Chem. 1994 May 13;37(10):1526-34. doi: 10.1021/jm00036a019. J Med Chem. 1994. PMID: 8182711

4

Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.

Müller CE, Geis U, Grahner B, Lanzner W, Eger K. Müller CE, et al. J Med Chem. 1996 Jun 21;39(13):2482-91. doi: 10.1021/jm960011w. J Med Chem. 1996. PMID: 8691445

5

Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.

Müller CE, Geis U, Hipp J, Schobert U, Frobenius W, Pawłowski M, Suzuki F, Sandoval-Ramírez J. Müller CE, et al. J Med Chem. 1997 Dec 19;40(26):4396-405. doi: 10.1021/jm970515+. J Med Chem. 1997. PMID: 9435909

6

8-(Sulfostyryl)xanthines: water-soluble A2A-selective adenosine receptor antagonists.

Müller CE, Sandoval-Ramírez J, Schobert U, Geis U, Frobenius W, Klotz KN. Müller CE, et al. Bioorg Med Chem. 1998 Jun;6(6):707-19. doi: 10.1016/s0968-0896(98)00025-x. Bioorg Med Chem. 1998. PMID: 9681137

7

Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists.

Sauer R, Maurinsh J, Reith U, Fülle F, Klotz KN, Müller CE. Sauer R, et al. Among authors: muller ce. J Med Chem. 2000 Feb 10;43(3):440-8. doi: 10.1021/jm9911480. J Med Chem. 2000. PMID: 10669571

8

Adenosine receptor ligands-recent developments part I. Agonists.

Muller CE. Muller CE. Curr Med Chem. 2000 Dec;7(12):1269-88. doi: 10.2174/0929867003374101. Curr Med Chem. 2000. PMID: 11032971 Review.

9

7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.

Hess S, Müller CE, Frobenius W, Reith U, Klotz KN, Eger K. Hess S, et al. Among authors: muller ce. J Med Chem. 2000 Nov 30;43(24):4636-46. doi: 10.1021/jm000967d. J Med Chem. 2000. PMID: 11101355

10

[(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors.

Müller CE, Diekmann M, Thorand M, Ozola V. Müller CE, et al. Bioorg Med Chem Lett. 2002 Feb 11;12(3):501-3. doi: 10.1016/s0960-894x(01)00785-5. Bioorg Med Chem Lett. 2002. PMID: 11814828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

573 results

Search Page

Filters